![A. Western blot analysis for EGFR, pEGFR (Y1068), Akt, pAkt and B. CDH5... | Download Scientific Diagram A. Western blot analysis for EGFR, pEGFR (Y1068), Akt, pAkt and B. CDH5... | Download Scientific Diagram](https://www.researchgate.net/publication/304662889/figure/fig2/AS:393666133807112@1470868728464/A-Western-blot-analysis-for-EGFR-pEGFR-Y1068-Akt-pAkt-and-B-CDH5-in-A549-lung.png)
A. Western blot analysis for EGFR, pEGFR (Y1068), Akt, pAkt and B. CDH5... | Download Scientific Diagram
![IJMS | Free Full-Text | Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines | HTML IJMS | Free Full-Text | Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines | HTML](https://www.mdpi.com/ijms/ijms-21-08805/article_deploy/html/images/ijms-21-08805-g007.png)
IJMS | Free Full-Text | Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines | HTML
![Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model - Sarcar - 2019 - FEBS Open Bio - Wiley Online Library Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model - Sarcar - 2019 - FEBS Open Bio - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/5cf574ef-8908-4aa7-b6a4-6f10f6c37200/feb412702-fig-0005-m.jpg)
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model - Sarcar - 2019 - FEBS Open Bio - Wiley Online Library
![Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma](https://www.spandidos-publications.com/article_images/or/32/3/OR-32-03-1188-g02.jpg)
Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma
![Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway](https://www.spandidos-publications.com/article_images/mmr/20/4/MMR-20-04-3317-g03.jpg)